UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 333- 141327

 

 

CHINA DASHENG BIOTECHNOLOGY CO.

 

(Exact name of registrant as specified in its charter)

 

 

P.O Box 26496, Scottsdale, AZ 85255

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Common Stock, par value $0.001 per share

 

(Title of each class of securities covered by this Form)

 

 

None

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     
Rule 12g-4(a)(1) o   Rule 12h-3(b)(1)(i)  o
Rule 12g-4(a)(2) o   Rule 12h-3(b)(1)(ii) o
    Rule 15d-6              o

 

Approximate number of holders of record as of the certification or notice date: 10

 

Pursuant to the requirements of the Securities Exchange Act of 1934, China Dasheng Biotechnology CO. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

         
     
Date: March 7, 2017 By:   /s/ Rhonda Keaveney  
    Name:   Rhonda Keaveney  
    Title:   Interim Officer and Director  
 

China Dasheng Biotechnol... (PK) (USOTC:CDBT)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos China Dasheng Biotechnol... (PK).
China Dasheng Biotechnol... (PK) (USOTC:CDBT)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos China Dasheng Biotechnol... (PK).